Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors), BACE1 inhibitors(Beta-secretase 1 inhibitors), BChE inhibitors(Butyrylcholinesterase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H46N2O3 |
InChIKeyCYQUVORXHWTTLL-UHFFFAOYSA-N |
CAS Registry2905309-45-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | IN | 22 Feb 2023 |